Tg Therapeutics (TGTX) Cost of Revenue (2021 - 2026)
Tg Therapeutics (TGTX) posted Cost of Revenue of $41.19 million for Q2 2026, up 117.5% from $18.94 million a year earlier and up 22.9% from the prior quarter.
Powered by 
Analysis
Tg Therapeutics (TGTX) Cost of Revenue (2021 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Cost of Revenue at Tg Therapeutics was $140.94 million, up 138.0% year-over-year; for FY2025, it was $100.71 million, up 161.7% from FY2024.
- Annual Cost of Revenue shows a four-year compound annual growth rate of 236.0% (FY2021 to FY2025).
- In prior years, Tg Therapeutics' Cost of Revenue was $38.49 million in FY2024 (+172.4%), $14.13 million in FY2023, $265,000 in FY2022 (-66.5%) and $790,000 in FY2021.
- The Q2 2026 figure stands as the highest quarterly Cost of Revenue in data going back to Q1 2021.
- On a year-over-year basis, Cost of Revenue has increased in each of the last ten quarters, with growth averaging 144.7% over the last eight quarters.
- Across the past five years, year-over-year growth in Cost of Revenue ran from 96.1% in Q4 2024 to 534.9% in Q1 2024.
- According to Business Quant data, Cost of Revenue for the three prior quarters was $33.51 million (Q1 2026), $38.14 million (Q4 2025) and $28.09 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 3.27 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 8.05 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 4.29 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 4.40 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 3.71 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 2.52 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 2.81 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 1.58 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 4.09 Bn |
| 10 | Tg Therapeutics | 8.31 Bn | 7.70 Bn | 199.14 Mn | 41.19 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 41.19 Mn |
| Mar 31, 2026 | 33.51 Mn |
| Dec 31, 2025 | 38.14 Mn |
| Sep 30, 2025 | 28.09 Mn |
| Jun 30, 2025 | 18.94 Mn |
| Mar 31, 2025 | 15.54 Mn |
| Dec 31, 2024 | 15.40 Mn |
| Sep 30, 2024 | 9.34 Mn |
| Jun 30, 2024 | 8.30 Mn |
| Mar 31, 2024 | 5.44 Mn |
| Dec 31, 2023 | 7.85 Mn |
| Sep 30, 2023 | 3.51 Mn |
| Jun 30, 2023 | 1.91 Mn |
| Mar 31, 2023 | 857,000.00 |
| Dec 31, 2022 | 3,000.00 |
| Sep 30, 2022 | 2,000.00 |
| Mar 31, 2021 | 139,000.00 |
API Access
Tg Therapeutics Cost of Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=TGTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cost-of-revenue", "ticker": "TGTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=TGTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();